Anlon Healthcare Intrinsic Value
Anlon Healthcare intrinsic value. Anlon Healthcare (AHCL) median intrinsic value is ₹78.05 from 8 valuation models (range ₹60–₹94), vs current price ₹31.22 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. For current market price and key ratios, visit AHCL share price.
AHCL Valuation Methods Summary — DCF, Graham Number & P/E
Anlon Healthcare intrinsic value across 8 models vs current price ₹31.22 — upside/downside and value range per method. Compare with AHCL DCF valuation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹93.66 | ₹74.93 - ₹112.39 | +200.0% | EPS: ₹9.32, Sector P/E: 22x |
| Book Value Method | asset | ₹78.05 | ₹70.25 - ₹85.86 | +150.0% | Book Value/Share: ₹48.11, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹62.44 | ₹56.20 - ₹68.68 | +100.0% | Revenue/Share: ₹38.49, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹62.44 | ₹56.20 - ₹68.68 | +100.0% | EBITDA: ₹60.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹59.65 | ₹53.69 - ₹65.62 | +91.1% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹93.66 | ₹84.29 - ₹103.03 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹62.44 | ₹56.20 - ₹68.68 | +100.0% | ROE: 17.3%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹93.66 | ₹84.29 - ₹103.03 | +200.0% | EPS: ₹9.32, BVPS: ₹48.11 |
AHCL Intrinsic Value vs Market Price — All Valuation Models
Anlon Healthcare fair value range ₹60–₹94 vs current market price ₹31.22 across 8 valuation models. Read AHCL dividend growth for the complete payout history and dividend yield track record.
AHCL Intrinsic Value Analysis — Undervalued or Overvalued?
Anlon Healthcare median intrinsic value ₹78.05, current price ₹31.22 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of AHCL?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Anlon Healthcare (AHCL) is ₹78.05 (median value). With the current market price of ₹31.22, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹59.65 to ₹93.66, indicating ₹59.65 - ₹93.66.
Is AHCL undervalued or overvalued?
Based on our multi-method analysis, Anlon Healthcare (AHCL) appears to be trading below calculated value by approximately 150.0%.
AHCL Financial Health — Key Ratios vs Industry Benchmarks
Anlon Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 25.67 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 17.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 30.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.55x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
AHCL Cash Flow Quality — Operating & Free Cash Flow
Anlon Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-59 Cr | ₹-77 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-22 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |